$GEVO

Bowron Kimberly T sold $2K of GEVO

Bowron Kimberly T (Chief of Staff) sold 1,221 shares of Gevo, Inc. (GEVO) at $1.71 on 2026-09-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bowron Kimberly T
Published Sep 4, 2026, 9:24 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$GEVO
Neutral
high confidence
Mentioned
$GEVO
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GEVONeutralLow
01

Why it matters

The disclosed sale does not alter valuation metrics or market perception.

02

Market read

Routine insider sale with negligible market impact.

03

What to watch

Potential future 10b5-1 sales could accumulate, but current filing is isolated.

Relevance 2/10Novelty 2/10Timing: filing date 2026-09-04 (post‑market)

Background

Form 4 filings disclose insider trades; Gevo is a small-cap renewable fuels company.

Company-level read

Ticker impact

$GEVONeutralHigh confidence
Context

Chief of Staff Bowron Kimberly T sold 1,221 shares for $2,088 via a 10b5-1 plan on 2026-09-03.

Expected impact

No material move expected.

Evidence & confidence

Small dollar amount and pre‑arranged plan indicate no new information for investors.

Market effects

None; Gevo operates in renewable fuels niche.

No regional effect.

Minimal.

Counterpoint

Even small insider sales can signal confidence issues, but size is too trivial.

Key entities

  • Bowron Kimberly T

    Chief of Staff at Gevo, Inc.

  • Gevo, Inc.

    NASDAQ‑listed renewable fuels producer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GEVOMedAI 8/10

Gevo (GEVO) Q2 2026 Earnings Call Transcript

Gevo (GEVO) reported Q2 2026 revenue of $47 million, up 7% year over year, and non-GAAP adjusted EBITDA of $11 million. Full-year 2026 adjusted EBITDA guidance is now above $60 million. The company targets $70 million of 45Z tax credit monetization in 2026 and recorded a $176 million noncash impairment tied to exiting its ATJ-60 project.

$GEVOHigh

Gevo, Inc. (GEVO): Results of Operations and Financial Condition

Gevo, Inc. (GEVO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Gevo Reports Second Quarter Results and Raises Financial Expectations for Full-Year 2026 ENGLEWOOD, Colo. – August 6, 2026 – Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels, chemicals and carbon management, today announced its financial results for the second

$GEVOMedAI 8/10

Why Is Gevo (GEVO) Stock Rocketing Higher Today

Gevo (NASDAQ: GEVO) shares rose about 7.5% after the company said it expects 2026 non-GAAP Adjusted EBITDA to be more than double prior estimates. Gevo attributed the upgrade to new carbon pathways, higher production, and cost reductions, and it announced Todd Werpy, Ph.D., joining its board. The stock is volatile and trades at $1.68.